Premium
Recombinant soluble urokinase receptor as a scavenger for urokinase‐type plasminogen activator (uPA)
Author(s) -
Wilhelm O.,
Weidle U.,
Höhl S.,
Rettenberger P.,
Schmitt M.,
Graeff H.
Publication year - 1994
Publication title -
febs letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.593
H-Index - 257
eISSN - 1873-3468
pISSN - 0014-5793
DOI - 10.1016/0014-5793(94)80259-9
Subject(s) - urokinase receptor , plasminogen activator , urokinase , microbiology and biotechnology , receptor , transfection , recombinant dna , chinese hamster ovary cell , in vitro , matrigel , cell culture , chemistry , cancer cell , biology , biochemistry , cancer , endocrinology , gene , genetics
A recombinant soluble human urokinase receptor comprising amino acids 1–277 was cloned and transfected into CHO cells. The mutant protein (rec‐uPAR 277 ), purified from the CHO cell supernatant by affinity chromatography on immobilized urokinase (uPA), in a four‐fold excess, completely abolished the binding of FITC‐labeled pro‐uPA to the human ovarian cancer cell line, OV‐MZ‐6. This invasive and tumorigenic cancer cell line expresses uPA, its inhibitor PAI‐1, and the high‐affinity receptor for uPA, uPAR. Rec‐uPAR 277 significantly reduced the proliferation of OV‐MZ‐6 cells in a concentration‐dependent manner without altering the viability of the cells. Invasion of OV‐MZ‐6 cells tested in an in vitro Matrigel invasion assay was inhibited by rec‐uPAR 277 up to 75%. In conclusion, these results demonstrate that rec‐uPAR 277 can function as a scavenger for uPA in vitro by inhibiting proliferation and invasion of human cancer cells.